| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Call for action: Rare plasma related disorders
|
Chatzimarkakis, Jorgo
|
|
2009
|
11 |
4 |
p. 323-324
|
artikel
|
| 2 |
Challenges and priorities for patients with immune thrombocytopenic purpura and their physicians
|
George, James N.
|
|
2009
|
11 |
4 |
p. 299-305
|
artikel
|
| 3 |
Council Directive 89/381/EEC of June 1989
|
|
|
2009
|
11 |
4 |
p. 405-409
|
artikel
|
| 4 |
CPMP Position Statement: Non-Remunerated and Remunerated Donors Safety and Supply of Plasma Derived Medicinal Products
|
|
|
2009
|
11 |
4 |
p. 501-503
|
artikel
|
| 5 |
Current key priorities for the rare diseases patients community in the EU
|
Macchia-Bangsgaard, Flaminia
|
|
2009
|
11 |
4 |
p. 241-243
|
artikel
|
| 6 |
Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003
|
|
|
2009
|
11 |
4 |
p. 505-522
|
artikel
|
| 7 |
Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004
|
|
|
2009
|
11 |
4 |
p. 523-557
|
artikel
|
| 8 |
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001
|
|
|
2009
|
11 |
4 |
p. 411-499
|
artikel
|
| 9 |
Editorial
|
|
|
2009
|
11 |
4 |
p. 237-238
|
artikel
|
| 10 |
EU regulatory perspective on rare diseases: Focus on plasma protein related disorders
|
Kerr, Jacqueline
|
|
2009
|
11 |
4 |
p. 387-395
|
artikel
|
| 11 |
Foreword
|
Vassiliou, Androulla
|
|
2009
|
11 |
4 |
p. 235-236
|
artikel
|
| 12 |
Giving from the heart: Simple and complex blood and plasma ethics
|
Wallner, Jürgen
|
|
2009
|
11 |
4 |
p. 371-384
|
artikel
|
| 13 |
Global issues facing the ITP community
|
Watson, Shirley
|
|
2009
|
11 |
4 |
p. 269-274
|
artikel
|
| 14 |
Global plasma demand in 2015
|
Robert, Patrick
|
|
2009
|
11 |
4 |
p. 359-367
|
artikel
|
| 15 |
Healthcare funding: Rare diseases, a priority? AIM's proposals
|
Budde, Willi
|
|
2009
|
11 |
4 |
p. 335-341
|
artikel
|
| 16 |
Immunoglobulin use in management of inflammatory neuropathy
|
Koski, Carol Lee
|
|
2009
|
11 |
4 |
p. 307-315
|
artikel
|
| 17 |
Key challenges and opportunities faced by people with a primary immunodeficiency throughout the world
|
Drabwell, Jose
|
|
2009
|
11 |
4 |
p. 261-263
|
artikel
|
| 18 |
Primary immunodeficiencies
|
Espanol, Teresa
|
|
2009
|
11 |
4 |
p. 277-283
|
artikel
|
| 19 |
Priorities for the alpha-1 community: The physicians perspective
|
Chotirmall, Sanjay Haresh
|
|
2009
|
11 |
4 |
p. 285-297
|
artikel
|
| 20 |
Rare diseases treated by plasma proteins
|
O'Mahony, Brian
|
|
2009
|
11 |
4 |
p. 245-257
|
artikel
|
| 21 |
Supply challenges: The collector's view
|
Naylor, Gordon
|
|
2009
|
11 |
4 |
p. 353-357
|
artikel
|
| 22 |
Tackling barriers to treatment access: The need for stakeholders dialogue
|
Prevot, Johan
|
|
2009
|
11 |
4 |
p. 325-332
|
artikel
|
| 23 |
The concerns and problems facing Alpha-1 Antitrypsin Deficiency patients
|
Warren, Larry
|
|
2009
|
11 |
4 |
p. 265-267
|
artikel
|
| 24 |
The rare diseases agenda of the European Parliament
|
Chatzimarkakis, Jorgo
|
|
2009
|
11 |
4 |
p. 319-321
|
artikel
|
| 25 |
Trialing plasma protein therapies for rare disorders: Thinking outside the box
|
Farrugia, Albert
|
|
2009
|
11 |
4 |
p. 345-352
|
artikel
|
| 26 |
US regulatory framework for rare plasma protein diseases
|
Weinstein, Mark
|
|
2009
|
11 |
4 |
p. 397-402
|
artikel
|
Tijdschrift beschrijving